AMLX vs W · rev $87.4M vs rev $11.85B
Amylyx Pharmaceuticals Inc (AMLX) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
AMLX currently screens at market cap $561.6M. W currently screens at market cap $10.77B.
Not investment advice. Open the AMLX and W stock pages for the full models.
Not investment advice.